Investigative Treatment for ENPP1 Deficiency Has Moved to Phase 1/2 Clinical Trial

Inozyme Pharma has recently announced that the first patient was dosed in its Phase 1/2 clinical trial of INZ-701 in adult patients with ABCC6 Deficiency and the second cohort in…

Continue Reading Investigative Treatment for ENPP1 Deficiency Has Moved to Phase 1/2 Clinical Trial